Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Pharmaceutical Technology

JUNE 16, 2023

The Phase IIa trial (NCT05734040) in Australia will see a potential 500 volunteers given OVX836 in combination with quadrivalent influenza vaccines (QIVs). The developer has tested OVX836 in four completed clinical trials. The aim of the latest ongoing trial is to evaluate the vaccine in a larger and more diverse population.

Vaccine 246

Vaccine Vaccination Trials Immune Response 246

NY Times

DECEMBER 11, 2020

British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.

Allergies 140

Allergies Vaccine Vaccination Clinical Trials 140

pharmaphorum

DECEMBER 23, 2021

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. billion last year, is also developing immunotherapies for other indications including egg and multi-tree nut allergies.

Allergies 124

Allergies Drugs Clinical Trials Clinical Trials 124

Velocity Clinical Research

OCTOBER 21, 2024

For a clinical trials organization to achieve this level of scale is notable. The clinical trials sector in the US is typically made up of small independent businesses that collectively play an important role in trialing new protocols and aiding drug development. Velocity is among the few exceptions.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

Antidote

SEPTEMBER 1, 2023

As part of our efforts to better understand patients and their motivations to participate in clinical trials, Antidote and SCORR Marketing partnered on a survey to gain a deeper understanding of how patients think about the medical research process.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Allergies 95

Clinical Trial Podcast

SEPTEMBER 26, 2022

To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials. The post Complexity in Early Phase Clinical Trials with Dr. The post Complexity in Early Phase Clinical Trials with Dr. Oren Cohen?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

Scienmag

NOVEMBER 18, 2021

Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can […].

Clinical Trials 86

Clinical Trials Clinical Trials Trial Funding Trials 86

Rethinking Clinical Trials

NOVEMBER 29, 2022

The NIH Pragmatic Trials Collaboratory is excited to welcome the INSPIRE Demonstration Project to its portfolio of innovative, large-scale pragmatic clinical trials embedded in healthcare systems. Although fewer than 5% of such patients have an antibiotic-resistant infection, more than half receive extended-spectrum antibiotics.

Trials 130

Trials Clinical Trials Clinical Trials Allergies 130

Pharmaceutical Technology

SEPTEMBER 16, 2022

The latest conditional recommendation is based on the final data from the SOLIDARITY clinical trial, which was sponsored by the WHO. These results are in line with those obtained from the placebo-controlled, double-blind ACTT-1 trial of the National Institute of Allergy and Infectious Diseases.

Allergies 277

Allergies RNA Clinical Trials Clinical Trials 277

Scienmag

JANUARY 20, 2022

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

Allergies 89

Allergies Trial Funding Clinical Trials Clinical Trials 89

XTalks

MARCH 10, 2025

Originally approved by the FDA over two decades ago for the treatment of moderate to severe persistent asthma, Xolair recently also gained approval for managing food allergies. In a global Phase III clinical trial, 619 adult patients were enrolled and received either 150 mg or 300 mg of omalizumab-igec every four weeks.

Allergies 66

Allergies FDA Approval Antibody Trials 66

XTalks

FEBRUARY 24, 2025

Carlsbad, California-based Ionis Pharmaceuticals announced it will be sharing promising new trial data for its RNA-targeted prophylactic treatment donidalorsen for hereditary angioedema (HAE) at the 2025 American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress in San Diego, California.

Trials 59

Trials RNA Allergies Drugs 59

Medical Xpress

FEBRUARY 28, 2023

A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

Allergies 75

Allergies Clinical Trials Clinical Trials Medicine 75

XTalks

NOVEMBER 6, 2020

Canadian clinical-stage biotech company Symvivo Corporation has developed an oral COVID-19 vaccine that entered clinical trials this week. The first healthy volunteer was dosed with the vaccine in Australia as part of the bacTRL-Spike COVID-19 Phase I clinical trial. COVID-19 Clinical Trials.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccine Vaccination 75

Scienmag

APRIL 21, 2021

Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

Antibody 81

Antibody Clinical Trials Clinical Trials Trials 81

Pharmaceutical Technology

JULY 18, 2022

According to positive interim data from the Phase II/III KidCOVE clinical trial, the vaccine offered a strong neutralising antibody response in children of the age group of six months to five years following administration of the two-dose initial regimen of the mRNA-1273 vaccine.

Vaccine 246

Vaccine Vaccination Gene Therapy Antibody 246

World of DTC Marketing

OCTOBER 6, 2021

In the first 29 days of the trial, no deaths were reported among the 385 patients who received the drug, while eight of the people who received a placebo died, according to the statement put out by Merck and Ridgeback Biotherapeutics, the two companies that are jointly launching it. million for NIH-funded clinical trials.

Clinical Trials 198

Clinical Trials Clinical Trials Allergies Trials 198

BioTech 365

OCTOBER 29, 2021

Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Peanut Allergy – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s (..)

Allergies 40

Allergies Clinical Trials Clinical Trials Trials 40

Rethinking Clinical Trials

JANUARY 24, 2023

INSPIRE is studying the effectiveness of a personalized clinical decision support program in improving antibiotic prescribing for non–critically ill patients hospitalized with abdominal infections or skin and soft tissue infections.

Allergies 130

Allergies Clinical Trials Clinical Trials Trials 130

Pharmaceutical Technology

JANUARY 8, 2023

There are at least six different biologics being studied in Phase III trials in COPD clinical programmes around the world. Results from a Phase III trial with Sanofi and Regeneron Pharmaceuticals’ IL-4/IL-13 monoclonal antibody (mAb) Dupixent (dupilumab) are expected by mid-2023, followed by others. Ongoing efforts.

Antibody 298

Antibody Trials Clinical Trials Clinical Trials 298

Scienmag

MAY 25, 2021

May 25, 2021 — Critical Path Institute (C-Path) today announced its schedule for the Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Workshop, to be held virtually June 15-16. Together […].

Clinical Trials 73

Clinical Trials Clinical Trials Trials Development 73

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). This trial will evaluate the safety of the vaccine and generate efficacy data. Intravacc has received a contract worth $14.6m

Vaccine 147

Vaccine Vaccination Development Bacterium 147

VirTrial

JULY 7, 2024

In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. In these ways, the two assessments measure BSA quite differently.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Dermatology 59

Medical Xpress

MARCH 6, 2023

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. A non-temperature stable form of the candidate previously had been tested in several clinical trials.

Immune Response 75

Immune Response Vaccine Vaccination Trials 75

STAT News

SEPTEMBER 12, 2022

National Institutes of Health is launching a Phase 3 clinical trial to determine the efficacy of tecovirimat — the smallpox antiviral better known as TPOXX — for use in treating monkeypox, as current data on its effectiveness against the virus is limited , The Hill writes. The TPOXX was approved by the U.S.

FDA Approval 98

FDA Approval Trials Clinical Trials Clinical Trials 98

XTalks

AUGUST 13, 2020

As the rush for a COVID-19 vaccine continues, healthcare services company Kaiser Permanente has joined in on the clinical testing of Pfizer Inc. and BioNTech’s lead vaccine candidate in a Phase III trial being conducted at sites in California and Oregon. Kaiser began Phase III trials of the vaccine at the end of July.

Vaccine 89

Vaccine Vaccination Trials Clinical Trials 89

Medical Xpress

JANUARY 30, 2023

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

Vaccine 104

Vaccine Vaccination Immune Response Allergies 104

Medical Xpress

JANUARY 17, 2023

A promising approach to control Staphylococcus aureus bacterial colonization in people—using a probiotic instead of antibiotics—was safe and highly effective in a Phase 2 clinical trial. aureus colonization in trial participants without harming the gut microbiota, which includes bacteria that can benefit people.

Trials 80

Trials Allergies Bacteria Clinical Trials 80

Antidote

NOVEMBER 20, 2023

In both 2018 and 2023, Antidote partnered with SCORR marketing to conduct surveys intended to increase the understanding of patients’ perceptions of clinical trials. Our 2018 survey collected data from nearly 4,000 individuals to gain insight into what matters most when considering a clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Allergies 52

JAMA Internal Medicine

JULY 16, 2023

This randomized clinical trial aims to determine whether a direct oral penicillin challenge is noninferior to the standard of care of penicillin skin testing followed by an oral challenge in patients with a low-risk penicillin allergy.

Allergies 56

Allergies Clinical Trials Clinical Trials Trials 56

Rethinking Clinical Trials

FEBRUARY 2, 2023

Russell, MD Assistant Professor, Department of Medicine Co-Director, Program in Medical ICU Research Division of Pulmonary, Allergy & Critical Care Medicine Assistant Medical Director, Birmingham Veterans Affairs Medical Center MICU University of Alabama at Birmingham Heersink School of Medicine Matthew W.

Trials 100

Trials Clinical Trials Clinical Trials Medicine 100

VirTrial

JULY 7, 2024

In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. In these ways, the two assessments measure BSA quite differently.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52

VirTrial

JULY 7, 2024

In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. In these ways, the two assessments measure BSA quite differently.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52

Rethinking Clinical Trials

JUNE 6, 2023

The purpose of the trial is to reduce unnecessary broad-spectrum antibiotic use in non-intensive care unit inpatients. The 12-month trial is currently in month 5, and the team has already seen a downward inflection in broad-spectrum antibiotic use.

Trials 130

Trials Clinical Trials Clinical Trials Allergies 130